Anti-aging shot for eye disease edges closer to reality

A Boston biotech startup injects its first human patient with an anti-aging shot designed to make cells act younger.

A Boston biotech startup announced a major step towards reversing age-related vision loss. Their experimental gene therapy, ER100, aims to reprogram cells, making them act younger. Life Biosciences co-founder Dr. David Sinclair explains this treatment combats aging by addressing epigenetic information loss. This marks a milestone FDA human trial in the science of aging.